Cargando…

Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness

BACKGROUND: New digital technologies offer providers the promise of more accurately tracking patients’ medication adherence. It is unclear, however, whether access to such information will affect provider treatment decisions in the real world. METHODS: Using prescriber-reported information on patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafrin, Jason, Bognar, Katalin, Everson, Katie, Brauer, Michelle, Lakdawalla, Darius N, Forma, Felicia M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173173/
https://www.ncbi.nlm.nih.gov/pubmed/30323635
http://dx.doi.org/10.2147/CEOR.S175877
_version_ 1783361084706521088
author Shafrin, Jason
Bognar, Katalin
Everson, Katie
Brauer, Michelle
Lakdawalla, Darius N
Forma, Felicia M
author_facet Shafrin, Jason
Bognar, Katalin
Everson, Katie
Brauer, Michelle
Lakdawalla, Darius N
Forma, Felicia M
author_sort Shafrin, Jason
collection PubMed
description BACKGROUND: New digital technologies offer providers the promise of more accurately tracking patients’ medication adherence. It is unclear, however, whether access to such information will affect provider treatment decisions in the real world. METHODS: Using prescriber-reported information on patient non-compliance from health insurance claims data between 2008 and 2014, we examined whether prescribers’ knowledge of non-compliance was associated with different prescribing patterns for patients with serious mental illness (SMI). We examined patients who initiated an oral atypical antipsychotic, but were later objectively non-adherent to this treatment, defined as proportion of days covered (PDC) <0.8. We examined how a physician’s awareness of patient non-compliance (ICD-9 diagnosis code: V15.81) was correlated with the physician’s real-world treatment decisions for that patient. Treatment decisions studied included the share of patients who increased antipsychotic dose, augmented treatment, switched their antipsychotic, or used a long-acting injectable (LAI). RESULTS: Among the 286,249 patients with SMI who initiated an antipsychotic and had PDC <0.8, 4,033 (1.4%) had documented non-compliance. When prescribers documented non-compliance, patients were more likely to be switched to another antipsychotic (32.8% vs 24.7%, P<0.001), have their dose increased (24.4% vs 22.1%, P=0.004), or receive an LAI (0.09% vs 0.04%, P=0.008), but were less likely to have augmented therapy with another antipsychotic (1.1% vs 1.3%, P=0.035) than patients without documented non-compliance. CONCLUSION: Among SMI patients with documented non-compliance, the frequency of dose, medication switches, and LAI use were higher and augmentation was lower compared to patients without documented non-compliance. Access to adherence information may help prescribers more rapidly switch ineffective medications as well as avoid unnecessary medication augmentation.
format Online
Article
Text
id pubmed-6173173
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61731732018-10-15 Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness Shafrin, Jason Bognar, Katalin Everson, Katie Brauer, Michelle Lakdawalla, Darius N Forma, Felicia M Clinicoecon Outcomes Res Original Research BACKGROUND: New digital technologies offer providers the promise of more accurately tracking patients’ medication adherence. It is unclear, however, whether access to such information will affect provider treatment decisions in the real world. METHODS: Using prescriber-reported information on patient non-compliance from health insurance claims data between 2008 and 2014, we examined whether prescribers’ knowledge of non-compliance was associated with different prescribing patterns for patients with serious mental illness (SMI). We examined patients who initiated an oral atypical antipsychotic, but were later objectively non-adherent to this treatment, defined as proportion of days covered (PDC) <0.8. We examined how a physician’s awareness of patient non-compliance (ICD-9 diagnosis code: V15.81) was correlated with the physician’s real-world treatment decisions for that patient. Treatment decisions studied included the share of patients who increased antipsychotic dose, augmented treatment, switched their antipsychotic, or used a long-acting injectable (LAI). RESULTS: Among the 286,249 patients with SMI who initiated an antipsychotic and had PDC <0.8, 4,033 (1.4%) had documented non-compliance. When prescribers documented non-compliance, patients were more likely to be switched to another antipsychotic (32.8% vs 24.7%, P<0.001), have their dose increased (24.4% vs 22.1%, P=0.004), or receive an LAI (0.09% vs 0.04%, P=0.008), but were less likely to have augmented therapy with another antipsychotic (1.1% vs 1.3%, P=0.035) than patients without documented non-compliance. CONCLUSION: Among SMI patients with documented non-compliance, the frequency of dose, medication switches, and LAI use were higher and augmentation was lower compared to patients without documented non-compliance. Access to adherence information may help prescribers more rapidly switch ineffective medications as well as avoid unnecessary medication augmentation. Dove Medical Press 2018-10-02 /pmc/articles/PMC6173173/ /pubmed/30323635 http://dx.doi.org/10.2147/CEOR.S175877 Text en © 2018 Shafrin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Shafrin, Jason
Bognar, Katalin
Everson, Katie
Brauer, Michelle
Lakdawalla, Darius N
Forma, Felicia M
Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title_full Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title_fullStr Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title_full_unstemmed Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title_short Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
title_sort does knowledge of patient non-compliance change prescribing behavior in the real world? a claims-based analysis of patients with serious mental illness
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173173/
https://www.ncbi.nlm.nih.gov/pubmed/30323635
http://dx.doi.org/10.2147/CEOR.S175877
work_keys_str_mv AT shafrinjason doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness
AT bognarkatalin doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness
AT eversonkatie doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness
AT brauermichelle doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness
AT lakdawalladariusn doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness
AT formafeliciam doesknowledgeofpatientnoncompliancechangeprescribingbehaviorintherealworldaclaimsbasedanalysisofpatientswithseriousmentalillness